Speaker illustration

Doctor Vincent Algalarrondo

Hospital Bichat-Claude Bernard, Paris (France)

Member of:

European Society of Cardiology
European Heart Rythm Association

Tafamidis versus liver transplantation as first-line therapy for hereditary transthyretin amyloidosis

Event: ESC CONGRESS 2019

Topic: Infiltrative Myocardial Disease

Session: Hot topics in myocardial and pericardial diseases

Thumbnail

Surviving at least one year with a good functional status: analysis of the early deaths after primary implantation of intracardiac defibrillator.

Event: ESC CONGRESS 2017

Topic: Sudden death / resuscitation

Session: Sudden cardiac death

Thumbnail

Atrial fibrillation ablation.

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Devices / Artificial heart / CRT / ICD

Session: Allez les Bleus! Groundbreaking French contributions to cardiology

Thumbnail

Autonomic dysfunction and prediction of long term survival in transthyretin amyloidosis

Event: ESC CONGRESS 2016

Topic: Cardiomyopathies

Session: Cardiomyopathies

Thumbnail

This platform is supported by

logo Novo Nordisk